Kingswood Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9M Buy
9,066
+651
+8% +$665K 0.44% 41
2026
Q1
$7.74M Buy
8,415
+148
+2% +$150K 0.37% 53
2025
Q4
$8.88M Buy
8,267
+1,211
+17% +$1.16M 0.43% 39
2025
Q3
$5.38M Buy
7,056
+573
+9% +$426K 0.33% 66
2025
Q2
$5.05M Sell
6,483
-631
-9% -$490K 0.4% 46
2025
Q1
$5.87M Sell
7,114
-1,643
-19% -$1.37M 0.54% 27
2024
Q4
$6.76M Sell
8,757
-5,873
-40% -$4.86M 0.51% 30
2024
Q3
$13M Buy
14,630
+831
+6% +$747K 0.92% 14
2024
Q2
$12.5M Buy
13,799
+4,778
+53% +$3.82M 1.13% 12
2024
Q1
$7.02M Sell
9,021
-851
-9% -$606K 0.81% 16
2023
Q4
$5.75M Buy
9,872
+5,965
+153% +$3.48M 0.65% 23
2023
Q3
$4.56M Buy
3,907
+1,981
+103% +$1.02M 0.78% 23
2023
Q2
$903K Buy
+1,926
New +$808K 0.29% 90

Other funds holding LLY

Kingswood Wealth Advisors's LLY Position: Q2 2026 in Review

Kingswood Wealth Advisors increased its Eli Lilly (LLY) stake by 7.7% in Q2 2026, buying an estimated $665K and bringing the position to 9,066 shares worth $10.9M. The position accounts for 0.44% of the portfolio, ranked #41.

Kingswood Wealth Advisors first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $13M in Q3 2024. 1,615 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kingswood Wealth Advisors held 9,066 shares of Eli Lilly worth $10.9M as of Q2 2026.
  • Kingswood Wealth Advisors bought 651 Eli Lilly shares in Q2 2026, an estimated $665K.
  • Eli Lilly made up 0.44% of Kingswood Wealth Advisors's portfolio in Q2 2026, its #41 holding.
  • Kingswood Wealth Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • Kingswood Wealth Advisors's Eli Lilly position peaked at $13M in Q3 2024.
  • 1,615 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kingswood Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.